17x forward earnings with overstated competition risk.
Viva Systems is trading below historical PE and PS levels at 17x forward earnings, with overstated Salesforce threat.
Viva Systems trades at 17x forward earnings, below most software peers. The Salesforce competitive threat is overstated — only relevant to a small part of Viva's business. Strong Vault CRM adoption in pharma.